As of 2023-12-02, the Intrinsic Value of Abbvie Inc (ABBV) is
160.15 USD. This Abbvie valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 143.41 USD, the upside of Abbvie Inc is
11.70%.
The range of the Intrinsic Value is 104.45 - 313.15 USD
160.15 USD
Intrinsic Value
Abbvie Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
104.45 - 313.15 |
160.15 |
11.7% |
| DCF (Growth 10y) |
134.53 - 370.00 |
197.96 |
38.0% |
| DCF (EBITDA 5y) |
149.77 - 239.12 |
184.13 |
28.4% |
| DCF (EBITDA 10y) |
170.35 - 285.05 |
214.67 |
49.7% |
| Fair Value |
92.24 - 92.24 |
92.24 |
-35.68% |
| P/E |
110.76 - 193.00 |
152.43 |
6.3% |
| EV/EBITDA |
138.13 - 356.85 |
226.31 |
57.8% |
| EPV |
79.14 - 120.01 |
99.57 |
-30.6% |
| DDM - Stable |
27.56 - 84.02 |
55.79 |
-61.1% |
| DDM - Multi |
103.39 - 213.05 |
136.17 |
-5.0% |
Abbvie Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
253,196.10 |
| Beta |
0.24 |
| Outstanding shares (mil) |
1,765.54 |
| Enterprise Value (mil) |
300,655.10 |
| Market risk premium |
5.00% |
| Cost of Equity |
10.66% |
| Cost of Debt |
4.86% |
| WACC |
9.39% |